Table 2

 Emergency department (ED) studies

First authorDesignSettingNumberInduction agentPre-treatment?NMBAOutcome measuresLevel of evidence
ED, emergency department; DB RCT, double blind randomised controlled trial; NMBA, neuromuscular blocking agent; E, etomidate; M, midazolam; T, thiopentone; F, fentanyl; Sux, suxamethonium; Vec, vecuronium, Lido, lidocaine; defascic, defasciculating agent; Sats, oxygen saturation; BP, blood pressure; HR, heart rate. Level of evidence from SIGN.54
Smith28Prospective observationalED convenience sample34E 0.3 mg/kgVec 0.01 mg/kgSux 1.5–2.0 mg/kgBP, HR, Sats, myoclonus, sedationIII
Swanson29Retrospective reviewAeromedical setting53E 0.2–0.4 mg/kgLidocaine (12)Sux (42 patients)BPIII
Atropine (3)HR
Vec (3)
Sovoloke30Retrospective reviewUrban ED, Patients <10 years100E 0.37+/–0.15 mg/kgLidocaine (58%)99% paralyticsBPIII
Atropine (37%)(54% Sux)Need for corticosteroids
Schenarts31RCTED31E 0.3 mg/kgLidocaine or defascic (doctor’s discretion)Sux 1.0–1.5 mg/kgCosyntropin stimulation testIb
M 0.05–0.1 mg/kg
Sivilotti32DB RCTED86T 5 mg/kgD-tubocurare or VecSux 1.5 mg/kg7 day mortalityIb
F 5 mcg/kgBP/HR, “rapid intubations”
M 0.1 mg/kg
Woodward33Retrospectve reviewED trauma patients66E 0.2–0.4 mg/kgNo commentSux 1–2 mg/kg (51), Vec 0.1–0.3 mg/kg (5)BP/HRIII
Johnson34Prospective observationalED18E 0.3 mg/kgNo commentNo commentSedation, BP/HR, “other effects”III
Laurin35Retrospective reviewED54E 0.2–0.4 mg/kgNilSux 1–2 mg/kgBP/HRIII
Complications
Plewa36Prospective observationalED trauma patients20E 0.3 mg/kgNilSux (2)Attempts, BP/HR, other side effectsIII
Vec (4)
Choi37Prospective observationalED121E 10–20 mg (45)NilNo commentBPIII
M 2–4 mg (76)